The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Rubella Immunity in Pregnancy

Prenatal Screening for Rubella IgG to Prevent Congenital Rubella Syndrome

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Kadın Hastalıkları ve Doğum department. Book Appointment →

What is Rubella Immunity in Pregnancy?

Rubella (German measles) is a viral infection caused by rubella virus (Rubivirus, Togaviridae family) typically presenting as a mild self-limited illness with maculopapular rash, lymphadenopathy, and fever in adults.

When acquired during pregnancy, especially in the first 12 weeks, rubella causes congenital rubella syndrome (CRS) in 80–90% of fetuses with characteristic triad of cataracts, sensorineural hearing loss, and cardiac defects (PDA, peripheral pulmonary stenosis).

Routine prenatal serology for rubella IgG identifies immune (≥10 IU/mL) versus non-immune women; rubella IgM testing is performed only with suspected acute infection or known exposure.

MMR vaccine has dramatically reduced rubella incidence in countries with established immunization programs; CRS is now rare (<1 per 100,000 live births in vaccinated populations) but remains a significant public health concern in regions with low vaccine coverage.

Symptoms

Maternal rubella infection: mild prodromal symptoms (low-grade fever, malaise, lymphadenopathy especially postauricular), followed by maculopapular pink rash starting on face and spreading caudally, lasting 3–5 days; arthralgia/arthritis in adults
Up to 50% of rubella infections are subclinical in adults
Congenital rubella syndrome (CRS) features: ocular (cataracts, microphthalmia, retinopathy, glaucoma), cardiac (PDA, peripheral pulmonary stenosis), auditory (sensorineural hearing loss, most common), neurologic (microcephaly, intellectual disability, autism spectrum)
Extended CRS spectrum: blueberry muffin rash, hepatosplenomegaly, thrombocytopenia, growth restriction, late-onset disabilities (diabetes, panencephalitis)
Diagnosis of fetal infection: amniotic fluid PCR, fetal blood IgM, ultrasound features (microcephaly, cardiac defects, IUGR, hyperechogenic bowel)

Risk Factors

Women of reproductive age without prior MMR vaccination (especially recent immigrants from regions without routine immunization)
Healthcare workers, childcare workers, teachers in proximity to potentially infected populations
Travel to areas with active rubella circulation
Inadequate prenatal care without screening
Outbreaks in unvaccinated communities or during global pandemic disruptions
Most countries' MMR programs (introduction in 1969–70 in developed countries) have eliminated endemic rubella; sporadic imported cases remain

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Pregnant woman without documented rubella immunity
  • Rash illness during pregnancy compatible with rubella (urgent evaluation)
  • Known exposure to rubella case in non-immune pregnant woman
  • Suspected congenital rubella syndrome features on prenatal ultrasonography
  • Postpartum non-immune woman requiring MMR vaccination
  • Preconception counseling for women planning pregnancy who are non-immune

Treatment Methods

01
Routine prenatal screening: rubella IgG at first prenatal visit; immune if ≥10 IU/mL; if negative, document non-immune status and counsel on prevention
02
Pre-pregnancy counseling: women planning pregnancy should be screened for rubella immunity; if non-immune, MMR vaccination recommended with 1-month delay before conception (live attenuated vaccine contraindicated in pregnancy)
03
Pregnancy infection avoidance for non-immune women: avoid contact with persons with rash illness, avoid travel to outbreak areas, maintain hand hygiene, prompt evaluation of any rash illness
04
Suspected rubella infection during pregnancy: serology with rubella IgM and IgG with avidity testing; if IgM positive and IgG low avidity, suggests recent infection; PCR of nasal swab can detect viral RNA
05
Confirmed first-trimester rubella infection: detailed counseling about high risk of CRS (80–90% if <12 weeks), discussion of options including pregnancy continuation with prenatal monitoring (amniocentesis at 18–20 weeks for amniotic fluid PCR, fetal blood sampling) or termination per local laws and patient values
06
Second-trimester rubella infection: lower CRS risk (10–20% at 13–16 weeks, <5% after 16 weeks); detailed prenatal monitoring with serial ultrasonography
07
Postpartum vaccination: non-immune women receive MMR vaccine before discharge; not contraindicated during breastfeeding; counseling about contraception for 1 month after vaccination
08
Public health reporting: rubella infection during pregnancy and CRS are notifiable diseases; reporting facilitates outbreak investigation and prevention
09
Newborn evaluation if maternal infection: physical examination, ophthalmologic evaluation, hearing screening, echocardiography, neuroimaging if indicated, viral isolation and PCR; isolation precautions in newborn
10
Long-term follow-up of CRS infants: multidisciplinary care including ophthalmology, audiology, cardiology, developmental pediatrics, early intervention services
11
Population-level prevention: maintain ≥95% MMR vaccination coverage to achieve herd immunity; school entry immunization requirements; surveillance systems
12
Documentation: record rubella status in prenatal record, immunization registry, patient health record; counsel about continued vigilance during travel and outbreaks

Which Department to Visit?

You can visit our Kadın Hastalıkları ve Doğum department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Kadın Hastalıkları ve Doğum Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Regular Gynecological Check-up

Kadın Hastalıkları ve Doğum

Regular gynecological check-ups enable early diagnosis of many women's diseases and increase treatment success. It is recommended that every sexually active woman or woman over 21 see a gynecologist at least once a year.

Cervical Cancer

Kadın Hastalıkları ve Doğum

Cervical cancer develops from uncontrolled growth of cells in the cervix and is among the most common women's cancers worldwide. Precancerous lesions can be recognized with regular Pap smear and HPV testing.

HPV and Vaccination

Kadın Hastalıkları ve Doğum

HPV is a common virus transmitted sexually that can lead to certain types of cancer. Vaccination provides over 90% protection against high-risk HPV strains.

Ovarian Cyst

Kadın Hastalıkları ve Doğum

Ovarian cysts are fluid-filled sacs that form in or on the ovarian tissue. Most are asymptomatic and disappear spontaneously; however, large or complex cysts can cause pain and complications.

Endometriosis

Kadın Hastalıkları ve Doğum

Endometriosis affects about 10% of women of reproductive age, causing cyclic pelvic pain, dysmenorrhea, dyspareunia, and infertility; combined medical and laparoscopic treatment improves quality of life.

Uterine Fibroids

Kadın Hastalıkları ve Doğum

Uterine fibroids are benign tumors developing from the uterine muscle layer. They affect 20-50% of women of reproductive age; most are asymptomatic, but can cause bleeding and pain.

Polycystic Ovary Syndrome (PCOS)

Kadın Hastalıkları ve Doğum

PCOS is the most common endocrine disease affecting approximately 10% of women of reproductive age, characterized by androgen excess, ovulation disorder, and polycystic ovarian appearance.

Menopause

Kadın Hastalıkları ve Doğum

Menopause is the life stage defined by not having a period for 12 consecutive months and the natural cessation of ovarian function. The average age is 51, but it can vary between 45-55 years.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.